HSBC Holdings
VRNA

HSBC Holdings’s Verona Pharma VRNA Stock Holding History

HSBC Holdings’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,041
Closed -$259K – 3076
2022
Q4 		$259K Sell
10,041
-5,000
-33% -$66.6K ﹤0.01% 2637
2022
Q3 		$158K Hold
15,041
– – ﹤0.01% 2692
2022
Q2 		$69K Hold
15,041
– – ﹤0.01% 3099
2022
Q1 		$79K Hold
15,041
– – ﹤0.01% 3158
2021
Q4 		$102K Hold
15,041
– – ﹤0.01% 3139
2021
Q3 		$83K Hold
15,041
– – ﹤0.01% 2899
2021
Q2 		$101K Hold
15,041
– – ﹤0.01% 2848
2021
Q1 		$124K Hold
15,041
– – ﹤0.01% 2616
2020
Q4 		$105K Buy
+15,041
New +$102K ﹤0.01% 2945

Other funds holding VRNA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return